120 related articles for article (PubMed ID: 21505715)
1. Peri-operative platelet function testing: the potential for reducing ischaemic and bleeding risks.
Gurbel PA; Mahla E; Tantry US
Thromb Haemost; 2011 Aug; 106(2):248-52. PubMed ID: 21505715
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel response variability and the advent of personalised antiplatelet therapy. A bench to bedside journey.
Gurbel PA; Tantry US
Thromb Haemost; 2011 Aug; 106(2):265-71. PubMed ID: 21713326
[TBL] [Abstract][Full Text] [Related]
3. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
Motovska Z; Kala P
Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
[TBL] [Abstract][Full Text] [Related]
4. Platelet function testing and prediction of procedural bleeding risk.
Grove EL; Hossain R; Storey RF
Thromb Haemost; 2013 May; 109(5):817-24. PubMed ID: 23467639
[TBL] [Abstract][Full Text] [Related]
5. The use of platelet function testing in PCI and CABG patients.
Janssen PW; ten Berg JM; Hackeng CM
Blood Rev; 2014 May; 28(3):109-21. PubMed ID: 24745727
[TBL] [Abstract][Full Text] [Related]
6. Monitoring platelet function to reduce the risk of ischemic and bleeding complications.
Price MJ
Am J Cardiol; 2009 Feb; 103(3 Suppl):35A-39A. PubMed ID: 19166711
[TBL] [Abstract][Full Text] [Related]
7. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery.
Maltais S; Perrault LP; Do QB
Eur J Cardiothorac Surg; 2008 Jul; 34(1):127-31. PubMed ID: 18455412
[TBL] [Abstract][Full Text] [Related]
8. Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoring.
Metzler H; Prüller F; Münch A; Primus G; Kainz J; Hödl R; Rehak P
Eur J Anaesthesiol; 2010 Feb; 27(2):138-45. PubMed ID: 19593147
[TBL] [Abstract][Full Text] [Related]
9. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
10. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
Toth PP
Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
[TBL] [Abstract][Full Text] [Related]
12. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
[TBL] [Abstract][Full Text] [Related]
13. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
Chew DP; Huang Z; Pieper KS; White H; Mahaffey KW; Ferguson JJ; Califf RM; Aylward PG
Am Heart J; 2008 Feb; 155(2):239-44. PubMed ID: 18215592
[TBL] [Abstract][Full Text] [Related]
14. Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target.
Gurbel PA; Antonino MJ; Bliden KP; Dichiara J; Suarez TA; Singla A; Tantry US
Platelets; 2008 Dec; 19(8):595-604. PubMed ID: 19012177
[TBL] [Abstract][Full Text] [Related]
15. Platelet monitoring for PCI: is it really necessary?
Tantry US; Gurbel PA
Hamostaseologie; 2009 Nov; 29(4):368-75. PubMed ID: 19882080
[TBL] [Abstract][Full Text] [Related]
16. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
Kapetanakis EI; Medlam DA; Boyce SW; Haile E; Hill PC; Dullum MK; Bafi AS; Petro KR; Corso PJ
Eur Heart J; 2005 Mar; 26(6):576-83. PubMed ID: 15723815
[TBL] [Abstract][Full Text] [Related]
18. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
Steinhubl S; Roe MT
Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
[TBL] [Abstract][Full Text] [Related]
19. P2Y12 platelet function assay for assessment of bleeding risk in coronary artery bypass grafting.
Yu PJ; Cassiere HA; Dellis SL; Manetta F; Stein J; Hartman AR
J Card Surg; 2014 May; 29(3):312-6. PubMed ID: 24588751
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
Bevilacqua S; Alkodami AA; Volpi E; Cerillo AG; Berti S; Glauber M; Gianetti J
Ann Thorac Surg; 2009 Feb; 87(2):496-502. PubMed ID: 19161767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]